CARM1 and breast cancer: In support of this, we have found that iAs-mediated inhibition of an estrogen-responsive promoter in MCF7 breast cancer cells is functionally related to iAs effects on CARM1 and on SRC3/AIB1 a GRIP1 homologue that interacts with ERs (manuscript in preparation).